18F-AV-1451 positron emission tomography in Alzheimer’s disease and progressive supranuclear palsy
Abstract
The ability to assess the distribution and extent of tau pathology in Alzheimer's disease and progressive supranuclear palsy in vivo would help to develop biomarkers for these tauopathies and clinical trials of disease-modifying therapies. New radioligands for positron emission tomography have generated considerable interest, and controversy, in their potential as tau biomarkers. We assessed the radiotracer 18F-AV-1451 with positron emission...
Paper Details
Title
18F-AV-1451 positron emission tomography in Alzheimer’s disease and progressive supranuclear palsy
Published Date
Jan 24, 2017
Journal
Pages
aww340 - aww340
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History